Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc > Enterprise Value

Iovance Biotherapeutics Inc Enterprise Value Chart (IOVA)

Iovance Biotherapeutics Inc annual/quarterly Enterprise Value from 2010 to 2020.
  • Iovance Biotherapeutics Inc Enterprise Value for the quarter ending December 12, 2020 was $5,358m a 5.31% increase of 285m year over year
  • Iovance Biotherapeutics Inc Enterprise Value for the last 12 months ending December 12, 2020 was $5,358m a 5.31% increase of 285m year over year
  • Iovance Biotherapeutics Inc Annual Enterprise Value for 2020 was $5,358m a 0.00% decrease of 0m from 2019
  • Iovance Biotherapeutics Inc Annual Enterprise Value for 2020 was $5,358m a 6.87% increase of 368m from 2019
  • Iovance Biotherapeutics Inc Annual Enterprise Value for 2020 was $4,990m a -1.68% decrease of -84m from 2019
Other Valuation Metrics:
  • Iovance Biotherapeutics Inc Market Cap for the quarter ending March 03, 2018 was $1,512m a 69.68% increase of 1,053m year over year
  • Iovance Biotherapeutics Inc Price / Book for the quarter ending March 03, 2018 was 8.50 a 64.03% increase of 5.44 year over year
View Chart On Koyfin

Quarterly IOVA Enterprise Value Data

12/2020$5,358m
12/2020$5,358m
11/2020$4,990m
11/2020$5,073m
11/2020$4,862m
11/2020$4,748m
11/2020$4,776m
11/2020$4,644m
11/2020$4,664m
11/2020$4,651m

Annual IOVA Enterprise Value Data

2020$5,358m
2020$5,358m
2020$4,990m
2020$5,073m
2020$4,862m
2020$4,748m
2020$4,776m
2020$4,644m
2020$4,664m
2020$4,651m